Home » News (page 2)


Oxford Set To Start First UK Coronavirus Vaccine Trial Today

The first UK vaccine candidate to prevent coronavirus infection is set to begin clinical testing in human volunteers  today. Its developers at the University of Oxford hope to have 1m vaccine doses ready by September to carry out large-scale clinical trials during the autumn and, if all goes well, to ...

Read More »

JUST LANDED: A new TIF Publication on Blood & COVID-19

Is the new coronavirus transfusion transmittable? What is the guidance that internationally acclaimed bodies, such as the World Health Organisation (WHO), the US Centers for Disease Control and Prevention (CDC) and others provide with regard to adequacy and safety of blood and its products? This brand new informational guide about ...

Read More »

Novavax to start human trial for ‘ideal’ coronavirus vaccine candidate

The biotech company Novavax announced today that it has identified an “ideal” coronavirus vaccine candidate — and is set to launch the first clinical human trial in mid-May. The candidate, NVX-CoV2373, proved its ability to produce immune responses and high levels of antibodies against COVID-19 in pre-clinical animal trials, the Gaithersburg, ...

Read More »

IMPORTANT ANNOUNCEMENT: TIF reschedules the International Thalassaemia Day 2020 Celebrations for the 8th of September due to coronavirus

  Given the unprecedented global public health crisis brought on by the COVID-19 pandemic, TIF announces that the celebrations of the International Thalassaemia Day 2020 on the 8th of May, including all the Federation’s activities that were initially programmed, are rescheduled for Monday, 8 September 2020. TIF strongly urges its members ...

Read More »